143 related articles for article (PubMed ID: 20507648)
1. Dihydrotachysterol intoxication treated with pamidronate: a case report.
Jensterle M; Pfeifer M; Sever M; Kocjan T
Cases J; 2010 Mar; 3():78. PubMed ID: 20507648
[TBL] [Abstract][Full Text] [Related]
2. [Severe Vitamin D(dihydrotachysterol)-intoxication with temporary anemia and hypercalcemia responsive to bisphosphonates].
Blind E; Fassnacht M; Körber C; Körber-Hafner N; Reiners C; Allolio B
Dtsch Med Wochenschr; 2001; 126(12):T21-T24. PubMed ID: 12751020
[TBL] [Abstract][Full Text] [Related]
3. Hypercalcemia-induced renal insufficiency during therapy with dihydrotachysterol.
Jehle DR; Keller F; Schwarz A; Jehle PM
J Med; 1999; 30(1-2):39-50. PubMed ID: 10515239
[TBL] [Abstract][Full Text] [Related]
4. [Severe hypercalcemia of unusual cause, looking for the culprit: Case report and review of the literature].
Jalbert M; Mignot A; Gauchez AS; Dobrokhotov AC; Fourcade J
Nephrol Ther; 2018 Jun; 14(4):231-236. PubMed ID: 29709532
[TBL] [Abstract][Full Text] [Related]
5. Dihydrotachysterol therapy for hypoparathyroidism: consequences of inadequate monitoring. Five cases and a review.
Quack I; Zwernemann C; Weiner SM; Sellin L; Henning BF; Waldherr R; Büchner NJ; Stegbauer J; Vonend O; Rump LC
Exp Clin Endocrinol Diabetes; 2005 Jul; 113(7):376-80. PubMed ID: 16025398
[TBL] [Abstract][Full Text] [Related]
6. Current therapy of hypoparathyroidism--a survey of German endocrinology centers.
Schilling T; Ziegler R
Exp Clin Endocrinol Diabetes; 1997; 105(4):237-41. PubMed ID: 9285213
[TBL] [Abstract][Full Text] [Related]
7. Progressively increased serum 1,25-dihydroxyvitamin D2 concentration in a hypoparathyroid patient with protracted hypercalcemia due to vitamin D2 intoxication.
Sato K; Emoto N; Toraya S; Tsushima T; Demura H; Tsuji N; Inaba S; Takeuchi A; Kobayashi T
Endocr J; 1994 Aug; 41(4):329-37. PubMed ID: 8528347
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D replacement therapy and renal function. Calcitriol v dihydrotachysterol.
Hymes LC; Warshaw BL
Am J Dis Child; 1984 Dec; 138(12):1125-8. PubMed ID: 6548870
[TBL] [Abstract][Full Text] [Related]
10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
11. Unaccountable severe hypercalcemia in a patient treated for hypoparathyroidism with dihydrotachysterol.
Boots JM; Burghouts JT; Jansen JL
Neth J Med; 1999 Jan; 54(1):16-20. PubMed ID: 10048291
[TBL] [Abstract][Full Text] [Related]
12. A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators.
Chan JC; McEnery PT; Chinchilli VM; Abitbol CL; Boineau FG; Friedman AL; Lum GM; Roy S; Ruley EJ; Strife CF
J Pediatr; 1994 Apr; 124(4):520-8. PubMed ID: 8151464
[TBL] [Abstract][Full Text] [Related]
13. [Vitamin D-related progressive renal insufficiency in an elderly patient with postsurgical hypoparathyroidism associated with extensive brain calcification].
Fujiwara T
Nihon Jinzo Gakkai Shi; 2012; 54(1):40-7. PubMed ID: 22413579
[TBL] [Abstract][Full Text] [Related]
14. [Observations in vitamin D and dihydrotachysterol poisoning].
Ziegler R; Minne H; Raue F; Paar G; Delling G
Dtsch Med Wochenschr; 1975 Feb; 100(9):415-6, 419-23. PubMed ID: 1116468
[TBL] [Abstract][Full Text] [Related]
15. [Severe hypercalcemia due to vitamin D intoxication].
Chambellan-Tison C; Horen B; Plat-Wilson G; Moulin P; Claudet I
Arch Pediatr; 2007 Nov; 14(11):1328-32. PubMed ID: 17931839
[TBL] [Abstract][Full Text] [Related]
16. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
17. The management of hypoparathyroidism with 1alpha-hydroxyvitamin D3.
Heyburn PJ; Peacock M
Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():209s-214s. PubMed ID: 606418
[TBL] [Abstract][Full Text] [Related]
18. From hypocalcemia to hypercalcemia-an unusual clinical presentation of a patient with permanent postsurgical hypoparathyroidism.
Sundaresh V; Levine SN
J Clin Endocrinol Metab; 2015 Jan; 100(1):21-4. PubMed ID: 25303492
[TBL] [Abstract][Full Text] [Related]
19. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism.
Attie MF; Gill JR; Stock JL; Spiegel AM; Downs RW; Levine MA; Marx SJ
J Clin Invest; 1983 Aug; 72(2):667-76. PubMed ID: 6874959
[TBL] [Abstract][Full Text] [Related]
20. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation.
Caplan RH; Beguin EA
Obstet Gynecol; 1990 Sep; 76(3 Pt 2):485-9. PubMed ID: 2381632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
